Indeed, there are considerable numbers of studies on TP53 gene being as a target for carcinogens, with a specific TP53 mutations spectrum, mainly G: C→A: T transitions at CpG and non-CpG sites in bladder cancer [7,15,16]. This evidence concerns the gene TP53 and urinary bladder carcinoma.